Cite
MLA Citation
V.P. Werth et al.. “SAT0512 Safety and efficacy of lenabasum in refractory skin-predominant dermatomyositis subjects treated in an open label extension of trial jbt101-dm-001.” Annals of the rheumatic diseases, vol. 77, n.d., pp. 1111–1112. http://access.bl.uk/ark:/81055/vdc_100144719651.0x000051